{"entity":{"type":"insider","cik":"0001673991","url":"/insider/0001673991","json_url":"/insider/0001673991.json","name":"Hawryluk P. Kent","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2016-08-12","last":"2026-05-08","span_basis":"filed_date"},"name_variants":[{"name":"Hawryluk P. Kent","source":"filing","n_filings":6,"first_seen":"2016-08-12","last_seen":"2026-05-08"}],"transactions":[{"id":6088403,"accession":"0001193125-26-214574","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-214574","line_url":"/filing/0001193125-26-214574#line-1","is_derivative":false,"issuer_cik":"0001673991","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001673991","owner_cik":"0001673991","owner_name":"Hawryluk P. Kent","owner_display_name":"Hawryluk P. Kent","owner_url":"/insider/0001673991","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":607.0,"shares_display":"607","price_per_share":29.54,"price_display":"29.54","price_state":"stated","total_value":17930.78,"total_display":"17,930.78","total_whole":"17,931","shares_owned_after":727667.0,"shares_owned_after_display":"727,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-06","filed_date":"2026-05-08","scope":"insider"},{"id":6229382,"accession":"0001193125-26-107268","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-107268","line_url":"/filing/0001193125-26-107268#line-1","is_derivative":false,"issuer_cik":"0001673991","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001673991","owner_cik":"0001673991","owner_name":"Hawryluk P. Kent","owner_display_name":"Hawryluk P. Kent","owner_url":"/insider/0001673991","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18500.0,"shares_display":"18,500","price_per_share":28.4142,"price_display":"28.41","price_state":"stated","total_value":525662.7,"total_display":"525,662.70","total_whole":"525,663","shares_owned_after":486777.0,"shares_owned_after_display":"486,777","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-16","scope":"insider"},{"id":5025455,"accession":"0001193125-25-245411","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-245411","line_url":"/filing/0001193125-25-245411#line-1","is_derivative":false,"issuer_cik":"0001673991","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001673991","owner_cik":"0001673991","owner_name":"Hawryluk P. Kent","owner_display_name":"Hawryluk P. Kent","owner_url":"/insider/0001673991","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":13.6395,"price_display":"13.64","price_state":"stated","total_value":272790.0,"total_display":"272,790.00","total_whole":"272,790","shares_owned_after":468277.0,"shares_owned_after_display":"468,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-20","filed_date":"2025-10-21","scope":"insider"},{"id":4099130,"accession":"0000950170-25-014494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-014494","line_url":"/filing/0000950170-25-014494#line-1","is_derivative":false,"issuer_cik":"0001673991","issuer_name":"MBX Biosciences, Inc.","issuer_ticker":"MBX","issuer_name_source":null,"issuer_url":"/issuer/0001673991","owner_cik":"0001673991","owner_name":"Hawryluk P. Kent","owner_display_name":"Hawryluk P. Kent","owner_url":"/insider/0001673991","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":10.69,"price_display":"10.69","price_state":"stated","total_value":534500.0,"total_display":"534,500.00","total_whole":"534,500","shares_owned_after":448277.0,"shares_owned_after_display":"448,277","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-05","scope":"insider"},{"id":4420480,"accession":"0001596771-17-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001596771-17-000021","line_url":"/filing/0001596771-17-000021#line-1","is_derivative":false,"issuer_cik":"0001638287","issuer_name":"Gemphire Therapeutics Inc.","issuer_ticker":"GEMP","issuer_name_source":null,"issuer_url":"/issuer/0001638287","owner_cik":"0001673991","owner_name":"Hawryluk P. Kent","owner_display_name":"Hawryluk P. Kent","owner_url":"/insider/0001673991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":9.47,"price_display":"9.47","price_state":"stated","total_value":236750.0,"total_display":"236,750.00","total_whole":"236,750","shares_owned_after":81889.0,"shares_owned_after_display":"81,889","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-03-10","filed_date":"2017-03-14","scope":"insider"},{"id":3036807,"accession":"0001104659-16-139283","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-16-139283","line_url":"/filing/0001104659-16-139283#line-4","is_derivative":false,"issuer_cik":"0001638287","issuer_name":"Gemphire Therapeutics Inc.","issuer_ticker":"GEMP","issuer_name_source":null,"issuer_url":"/issuer/0001638287","owner_cik":"0001673991","owner_name":"Hawryluk P. Kent","owner_display_name":"Hawryluk P. Kent","owner_url":"/insider/0001673991","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":250000.0,"total_display":"250,000.00","total_whole":"250,000","shares_owned_after":56889.0,"shares_owned_after_display":"56,889","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-10","filed_date":"2016-08-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001776111","name":"MBX Biosciences, Inc.","url":"/issuer/0001776111","role":"Director, Officer (President & CEO)","n_filings":4,"first_seen":"2025-02-05","last_seen":"2026-05-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001638287","name":"Gemphire Therapeutics Inc.","url":"/issuer/0001638287","role":"Director","n_filings":2,"first_seen":"2016-08-12","last_seen":"2017-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001673991","retrieved_at":"2026-08-27T13:36:25+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}